N C Olson1, M Cushman1,2, S E Judd3, B M Kissela4, M M Safford5,6, G Howard3, N A Zakai1,2. 1. Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, VT, USA. 2. Department of Medicine, University of Vermont College of Medicine, Burlington, VT, USA. 3. Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA. 4. Department of Neurology and Rehabilitation Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA. 5. Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 6. Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Abstract
Essentials Coagulation factors (F) IX and XI have been implicated in cardiovascular disease (CVD) risk. We studied associations of FIX and FXI with incident coronary heart disease (CHD) and stroke. Higher FIX antigen was associated with incident CHD risk in blacks but not whites. Higher levels of FIX antigen may be a CHD risk factor among blacks. SUMMARY: Background Recent studies have suggested the importance of coagulation factor IX and FXI in cardiovascular disease (CVD) risk. Objectives To determine whether basal levels of FIX or FXI antigen were associated with the risk of incident coronary heart disease (CHD) or ischemic stroke. Patients/Methods The REasons for Geographic And Racial Differences in Stroke (REGARDS) study recruited 30 239 participants across the contiguous USA between 2003 and 2007. In a case-cohort study within REGARDS, FIX and FXI antigen were measured in participants with incident CHD (n = 609), in participants with incident ischemic stroke (n = 538), and in a cohort random sample (n = 1038). Hazard ratios (HRs) for CHD and ischemic stroke risk were estimated with Cox models per standard deviation higher FIX or FXI level, adjusted for CVD risk factors. Results In models adjusting for CHD risk factors, higher FIX levels were associated with incident CHD risk (HR 1.19; 95% confidence interval [CI] 1.01-1.40) and the relationship of higher FXI levels was slightly weaker (HR 1.15; 95% CI 0.97-1.36). When stratified by race, the HR of FIX was higher in blacks (HR 1.39; 95% CI 1.10-1.75) than in whites (HR 1.06; 95% CI 0.86-1.31). After adjustment for stroke risk factors, there was no longer an association of FIX levels with ischemic stroke, whereas the association of FXI levels with ischemic stroke was slightly attenuated. Conclusions Higher FIX antigen levels were associated with incident CHD in blacks but not in whites. FIX levels may increase CHD risk among blacks.
Essentials Coagulation factors (F) IX and XI have been implicated in cardiovascular disease (CVD) risk. We studied associations of FIX and FXI with incident coronary heart disease (CHD) and stroke. Higher FIX antigen was associated with incident CHD risk in blacks but not whites. Higher levels of FIX antigen may be a CHD risk factor among blacks. SUMMARY: Background Recent studies have suggested the importance of coagulation factor IX and FXI in cardiovascular disease (CVD) risk. Objectives To determine whether basal levels of FIX or FXI antigen were associated with the risk of incident coronary heart disease (CHD) or ischemic stroke. Patients/Methods The REasons for Geographic And Racial Differences in Stroke (REGARDS) study recruited 30 239 participants across the contiguous USA between 2003 and 2007. In a case-cohort study within REGARDS, FIX and FXI antigen were measured in participants with incident CHD (n = 609), in participants with incident ischemic stroke (n = 538), and in a cohort random sample (n = 1038). Hazard ratios (HRs) for CHD and ischemic stroke risk were estimated with Cox models per standard deviation higher FIX or FXI level, adjusted for CVD risk factors. Results In models adjusting for CHD risk factors, higher FIX levels were associated with incident CHD risk (HR 1.19; 95% confidence interval [CI] 1.01-1.40) and the relationship of higher FXI levels was slightly weaker (HR 1.15; 95% CI 0.97-1.36). When stratified by race, the HR of FIX was higher in blacks (HR 1.39; 95% CI 1.10-1.75) than in whites (HR 1.06; 95% CI 0.86-1.31). After adjustment for stroke risk factors, there was no longer an association of FIX levels with ischemic stroke, whereas the association of FXI levels with ischemic stroke was slightly attenuated. Conclusions Higher FIX antigen levels were associated with incident CHD in blacks but not in whites. FIX levels may increase CHD risk among blacks.
Authors: Zsuzsanna Ament; Amit Patki; Ninad Chaudhary; Varun M Bhave; Ana-Lucia Garcia Guarniz; Yan Gao; Robert E Gerszten; Adolfo Correa; Suzanne E Judd; Mary Cushman; D Leann Long; M Ryan Irvin; W Taylor Kimberly Journal: Neurology Date: 2022-03-09 Impact factor: 11.800
Authors: Alejandro Pallares Robles; Vincent Ten Cate; Andreas Schulz; Jürgen H Prochaska; Steffen Rapp; Thomas Koeck; Marina Panova-Noeva; Stefan Heitmeier; Stephan Schwers; Kirsten Leineweber; Hans-Jürgen Seyfarth; Christian F Opitz; Henri Spronk; Christine Espinola-Klein; Karl J Lackner; Thomas Münzel; Miguel A Andrade-Navarro; Stavros V Konstantinides; Hugo Ten Cate; Philipp S Wild Journal: Sci Rep Date: 2022-06-13 Impact factor: 4.996
Authors: Debora Kamin Mukaz; Neil A Zakai; Salvador Cruz-Flores; Louise D McCullough; Mary Cushman Journal: Stroke Date: 2020-10-26 Impact factor: 7.914
Authors: Ninad S Chaudhary; S Louis Bridges; Kenneth G Saag; Elizabeth J Rahn; Jeffrey R Curtis; Angelo Gaffo; Nita A Limdi; Emily B Levitan; Jasvinder A Singh; Lisandro D Colantonio; George Howard; Mary Cushman; Matthew L Flaherty; Suzanne Judd; Marguerite R Irvin; Richard J Reynolds Journal: Hypertension Date: 2019-12-02 Impact factor: 10.190
Authors: Neil A Zakai; Suzanne E Judd; Brett Kissela; George Howard; Monika M Safford; Mary Cushman Journal: Thromb Haemost Date: 2018-06-11 Impact factor: 5.249
Authors: Nicholas Wettersten; Mary Cushman; Virginia J Howard; Oliver Hartmann; Gerasimos Filippatos; Neil Beri; Paul Clopton; George Howard; Monika M Safford; Suzanne E Judd; Andreas Bergmann; Joachim Struck; Alan S Maisel Journal: Am J Cardiol Date: 2018-03-28 Impact factor: 2.778